Literature DB >> 27184854

TREX1 Knockdown Induces an Interferon Response to HIV that Delays Viral Infection in Humanized Mice.

Lee Adam Wheeler1, Radiana T Trifonova2, Vladimir Vrbanac3, Natasha S Barteneva2, Xing Liu2, Brooke Bollman2, Lauren Onofrey2, Sachin Mulik2, Shahin Ranjbar2, Andrew D Luster3, Andrew M Tager3, Judy Lieberman4.   

Abstract

Despite their antiviral effect, the in vivo effect of interferons on HIV transmission is difficult to predict, because interferons also activate and recruit HIV-susceptible cells to sites of infection. HIV does not normally induce type I interferons in infected cells, but does if TREX1 is knocked down. Here, we investigated the effect of topical TREX1 knockdown and local interferon production on HIV transmission in human cervicovaginal explants and humanized mice. In explants in which TREX1 was knocked down, HIV induced interferons, which blocked infection. In humanized mice, even though TREX1 knockdown increased infiltrating immune cells, it delayed viral replication for 3-4 weeks. Similarly intravaginal application of type I interferons the day before HIV infection induced interferon responsive genes, reduced inflammation, and decreased viral replication. However, intravenous interferon enhanced inflammation and infection. Thus, in models of human sexual transmission, a localized interferon response inhibits HIV transmission but systemic interferons do not.
Copyright © 2016 The Author(s). Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27184854      PMCID: PMC4881429          DOI: 10.1016/j.celrep.2016.04.048

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  51 in total

1.  Propagation and dissemination of infection after vaginal transmission of simian immunodeficiency virus.

Authors:  Christopher J Miller; Qingsheng Li; Kristina Abel; Eun-Young Kim; Zhong-Min Ma; Stephen Wietgrefe; Lisa La Franco-Scheuch; Lara Compton; Lijie Duan; Marta Dykhuizen Shore; Mary Zupancic; Marc Busch; John Carlis; Steven Wolinsky; Steven Wolinksy; Ashley T Haase
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

2.  Position-specific chemical modification of siRNAs reduces "off-target" transcript silencing.

Authors:  Aimee L Jackson; Julja Burchard; Devin Leake; Angela Reynolds; Janell Schelter; Jie Guo; Jason M Johnson; Lee Lim; Jon Karpilow; Kim Nichols; William Marshall; Anastasia Khvorova; Peter S Linsley
Journal:  RNA       Date:  2006-05-08       Impact factor: 4.942

Review 3.  The interplay between viruses and innate immune signaling: recent insights and therapeutic opportunities.

Authors:  Leonie Unterholzner; Andrew G Bowie
Journal:  Biochem Pharmacol       Date:  2007-08-06       Impact factor: 5.858

Review 4.  Dendritic-cell interactions with HIV: infection and viral dissemination.

Authors:  Li Wu; Vineet N KewalRamani
Journal:  Nat Rev Immunol       Date:  2006-11       Impact factor: 53.106

5.  Cell type-specific delivery of siRNAs with aptamer-siRNA chimeras.

Authors:  James O McNamara; Eran R Andrechek; Yong Wang; Kristi D Viles; Rachel E Rempel; Eli Gilboa; Bruce A Sullenger; Paloma H Giangrande
Journal:  Nat Biotechnol       Date:  2006-06-25       Impact factor: 54.908

6.  Sexual transmission and propagation of SIV and HIV in resting and activated CD4+ T cells.

Authors:  Z Zhang; T Schuler; M Zupancic; S Wietgrefe; K A Staskus; K A Reimann; T A Reinhart; M Rogan; W Cavert; C J Miller; R S Veazey; D Notermans; S Little; S A Danner; D D Richman; D Havlir; J Wong; H L Jordan; T W Schacker; P Racz; K Tenner-Racz; N L Letvin; S Wolinsky; A T Haase
Journal:  Science       Date:  1999-11-12       Impact factor: 47.728

7.  Sequence of human immunodeficiency virus type 1 (HIV-1) Gag localization and oligomerization monitored with live confocal imaging of a replication-competent, fluorescently tagged HIV-1.

Authors:  Wolfgang Hübner; Ping Chen; Armando Del Portillo; Yuxin Liu; Ronald E Gordon; Benjamin K Chen
Journal:  J Virol       Date:  2007-08-29       Impact factor: 5.103

8.  Characterization of the early steps of infection of primary blood monocytes by human immunodeficiency virus type 1.

Authors:  Vanessa Arfi; Lise Rivière; Loraine Jarrosson-Wuillème; Caroline Goujon; Dominique Rigal; Jean-Luc Darlix; Andrea Cimarelli
Journal:  J Virol       Date:  2008-04-16       Impact factor: 5.103

9.  HIV-induced type I interferon and tryptophan catabolism drive T cell dysfunction despite phenotypic activation.

Authors:  Adriano Boasso; Andrew W Hardy; Stephanie A Anderson; Matthew J Dolan; Gene M Shearer
Journal:  PLoS One       Date:  2008-08-13       Impact factor: 3.240

Review 10.  The interaction of HIV with dendritic cells: outcomes and pathways.

Authors:  Vincent Piguet; Ralph M Steinman
Journal:  Trends Immunol       Date:  2007-10-22       Impact factor: 16.687

View more
  19 in total

1.  Innate Immune Activation by cGMP-AMP Nanoparticles Leads to Potent and Long-Acting Antiretroviral Response against HIV-1.

Authors:  Chukwuemika Aroh; Zhaohui Wang; Nicole Dobbs; Min Luo; Zhijian Chen; Jinming Gao; Nan Yan
Journal:  J Immunol       Date:  2017-10-30       Impact factor: 5.422

2.  Development of IFN-Stimulated Gene Expression from Embryogenesis through Adulthood, with and without Constitutive MDA5 Pathway Activation.

Authors:  Laura Bankers; Caitlin Miller; Guoqi Liu; Chommanart Thongkittidilok; James Morrison; Eric M Poeschla
Journal:  J Immunol       Date:  2020-04-10       Impact factor: 5.422

Review 3.  Humanized Mouse Models for Human Immunodeficiency Virus Infection.

Authors:  Matthew D Marsden; Jerome A Zack
Journal:  Annu Rev Virol       Date:  2017-07-26       Impact factor: 10.431

Review 4.  The Role of Nucleic Acid Sensing in Controlling Microbial and Autoimmune Disorders.

Authors:  Keesha M Matz; R Marena Guzman; Alan G Goodman
Journal:  Int Rev Cell Mol Biol       Date:  2018-09-25       Impact factor: 6.813

5.  HIV-1 blocks the signaling adaptor MAVS to evade antiviral host defense after sensing of abortive HIV-1 RNA by the host helicase DDX3.

Authors:  Sonja I Gringhuis; Nina Hertoghs; Tanja M Kaptein; Esther M Zijlstra-Willems; Ramin Sarrami-Forooshani; Joris K Sprokholt; Nienke H van Teijlingen; Neeltje A Kootstra; Thijs Booiman; Karel A van Dort; Carla M S Ribeiro; Agata Drewniak; Teunis B H Geijtenbeek
Journal:  Nat Immunol       Date:  2016-12-26       Impact factor: 25.606

6.  HIV-1 Activation of Innate Immunity Depends Strongly on the Intracellular Level of TREX1 and Sensing of Incomplete Reverse Transcription Products.

Authors:  Swati Kumar; James H Morrison; David Dingli; Eric Poeschla
Journal:  J Virol       Date:  2018-07-31       Impact factor: 5.103

Review 7.  The use of humanized mice for studies of viral pathogenesis and immunity.

Authors:  Florian Douam; Alexander Ploss
Journal:  Curr Opin Virol       Date:  2018-03-28       Impact factor: 7.090

8.  Immunotherapy for breast cancer using EpCAM aptamer tumor-targeted gene knockdown.

Authors:  Ying Zhang; Xuemei Xie; Pourya Naderi Yeganeh; Dian-Jang Lee; David Valle-Garcia; Karla F Meza-Sosa; Caroline Junqueira; Jiayu Su; Hongbo R Luo; Winston Hide; Judy Lieberman
Journal:  Proc Natl Acad Sci U S A       Date:  2021-03-02       Impact factor: 11.205

Review 9.  The Interplay between Viruses and Host DNA Sensors.

Authors:  Sandra Huérfano; Vojtech Šroller; Kateřina Bruštíková; Lenka Horníková; Jitka Forstová
Journal:  Viruses       Date:  2022-03-23       Impact factor: 5.818

10.  Human Three Prime Repair Exonuclease 1 Promotes HIV-1 Integration by Preferentially Degrading Unprocessed Viral DNA.

Authors:  Benem-Orom Davids; Muthukumar Balasubramaniam; Nicklas Sapp; Prem Prakash; Shalonda Ingram; Min Li; Robert Craigie; Thomas Hollis; Jui Pandhare; Chandravanu Dash
Journal:  J Virol       Date:  2021-08-10       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.